Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study
暂无分享,去创建一个
Soo-Jeong Cho | Bokyung Kim | Eunwoo Lee | Hyun-Chae Chung | K. Han | Jin-Hyung Jung | S. Kang | S. Kim